Innovative Awards: IDEA (Innovative, Developmental, and Exploratory Awards)


2018 (Cycle 24)

  Top
Metformins in Triple-Negative Breast Cancer Immunotherapy
Award: $187,358
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Adipose-rich microenvironment in breast cancer
Award: $288,000
Institution: San Diego Biomedical Research Institute Subject Area: Pathogenesis
Targeting tumor-initiating niche to overcome chemoresistance
Award: $187,500
Institution: University of California, San Diego Subject Area: Innovative Treatments
Dietary asparagine limitation to augment immune therapy
Award: $255,867
Institution: Cedars-Sinai Medical Center Subject Area: Innovative Treatments
Targeting IGF2 and Androgen Receptors for TNBC Therapy
Award: $187,436
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Improving Health of Women on Aromatase Inhibitors
Award: $187,403
Institution: University of California, Los Angeles Subject Area: Innovative Treatments

2017 (Cycle 23)

  Top
Targeting heterochromatic RNAs in high risk breast cancer
Award: $291,000
Institution: Salk Institute for Biological Studies Subject Area: Pathogenesis
Novel compound to target breast cancer stem cells
Award: $292,500
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
A new targeted therapy for breast cancer
Award: $290,250
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Cancer stem cell-mediated immune escape.
Award: $187,500
Institution: University of California, Riverside Subject Area: Pathogenesis
Targeting metastatic TNBC by scavenging blood glutamate
Award: $188,680
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Targeting Internal Ribosome Entry Site Transacting Factors
Award: $236,225
Institution: Stanford University Subject Area: Pathogenesis

2016 (Cycle 22)

  Top
Preclinical analysis of MAD28 in inflammatory breast cancer
Award: $210,715
Institution: University of California, San Diego Subject Area: Innovative Treatments
Technologies for Augmented Reality Breast Surgery
Award: $232,647
Institution: Stanford University Subject Area: Innovative Treatments

2015 (Cycle 21)

  Top
Localized Probability of Mammographic Masking
Award: $124,112
Institution: University of California, San Francisco Subject Area: Innovative Treatments
High-resolution Dynamic PET for Breast Tumor Differentiation
Award: $186,042
Institution: University of California, Davis Subject Area: Innovative Treatments
Exploiting Senescence for Breast Cancer Prevention and Treat
Award: $292,500
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
Unique camel-human hybrid mAbs against pro-invasive MMP-14
Award: $241,174
Institution: University of California, Riverside Subject Area: Innovative Treatments
Identification of novel breast cancer therapeutic antibodies
Award: $299,273
Institution: SRI International Subject Area: Innovative Treatments
Cell-free tumor DNA in CSF decodes breast cancer brain mets
Award: $236,541
Institution: Stanford University Subject Area: Pathogenesis

2014 (Cycle 20)

  Top
Systemic metabolic reprogramming by BC-secreted microRNAs
Award: $52,753
Institution: University of California, San Diego Subject Area: Prevention & Risk Reduction
Gut microbiota in association with chemotherapy treatment
Award: $246,936
Institution: University of Southern California Subject Area: Innovative Treatments
Systemic metabolic reprogramming by BC-secreted microRNAs
Award: $180,515
Institution: Beckman Research Institute of the City of Hope Subject Area: Pathogenesis
Targeting Breast Cancer Metastasis to Bone
Award: $237,448
Institution: Stanford University Subject Area: Pathogenesis
A Novel TNBC Therapeutic Opportunity: Cystine Addiction
Award: $187,330
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Sulindac-derived compounds for breast cancer therapy
Award: $292,498
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments
CT guided DOT for Breast cancer imaging
Award: $187,500
Institution: University of California, Merced Subject Area: Imaging, Biomarkers, & Molecular Pathology
Persistent organic pollutants and mammographic density
Award: $247,534
Institution: University of Southern California Subject Area: Etiology
Breast Cancer and the Human Oral Microbiome
Award: $187,221
Institution: University of California, San Francisco Subject Area: Prevention & Risk Reduction
Drug to block double-strand break repair in breast cancer
Award: $160,500
Institution: Stanford University Subject Area: Innovative Treatments
Mechanical stressors and age as regulators of telomerase
Award: $208,900
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis

2013 (Cycle 19)

  Top
Vitamin D Signals Via a Novel Pathway to Inhibit Metastasis
Award: $236,068
Institution: Stanford University Subject Area: Innovative Treatments
Intranasal drug delivery for brain metastatic breast cancer
Award: $242,382
Institution: University of Southern California Subject Area: Innovative Treatments
Expression Profiling of Circulating Tumor Cells
Award: $244,591
Institution: University of Southern California Subject Area: Innovative Treatments
Getting a jump on cancer with a genomic risk classifier
Award: $251,119
Institution: Stanford University Subject Area: Etiology
Internal chemical exposure study among Mexican immigrants
Award: $124,414
Institution: University of California, San Francisco Subject Area: Etiology
Imaging, Genomics, and Glycoproteomics for Cancer Detection
Award: $235,348
Institution: Stanford University Subject Area: Imaging, Biomarkers, & Molecular Pathology
A first-in-class allosteric RAF inhibitor for breast cancer
Award: $187,500
Institution: University of California, San Diego Subject Area: Innovative Treatments
Radiation-Induced Migration of Breast Cancer Cells
Award: $234,189
Institution: Stanford University Subject Area: Innovative Treatments
Breast cancer and neurocognitive outcomes
Award: $267,092
Institution: Beckman Research Institute of the City of Hope Subject Area: Sociocultural, Behavioral, and Psychological Issues

2012 (Cycle 18)

  Top
Examining Metastatic Potential in Mammary Stem Cells
Award: $150,000
Institution: University of California, San Diego Subject Area: Biology of the Normal Breast
Maternal Folic Acid Intake, Mammary Development, and Cancer
Award: $149,944
Institution: University of California, Davis Subject Area: Etiology
Rescuing HR DNA Repair in BRCA1-Mutation Carriers
Award: $166,406
Institution: Beckman Research Institute of the City of Hope Subject Area: Pathogenesis
Sub-millimeter PET for Improving Outcomes in Breast Cancer
Award: $149,332
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology
Understanding HER3 and mTor Signaling in Breast Cancer
Award: $100,000
Institution: University of California, San Francisco Subject Area: Pathogenesis
Genetic Predictors of Chemotherapy Toxicity in Breast Cancer
Award: $99,998
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Compositional Mammography for Breast Cancer Detection
Award: $149,895
Institution: University of California, San Francisco Subject Area: Imaging, Biomarkers, & Molecular Pathology
Co-Targeting the Notch and EphB4 Receptors in Breast Cancer
Award: $243,362
Institution: University of Southern California Subject Area: Innovative Treatments
Host Hypoxia to Treat Breast Cancer Brain Metastasis
Award: $284,250
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Predicting BRCA1 Mutation Status from Tumor Pathology
Award: $245,821
Institution: University of Southern California Subject Area: Prevention & Risk Reduction
Establishing Cell Lifespans in Cancer and Normal Breast
Award: $155,728
Institution: University of California, Davis Subject Area: Pathogenesis

2011 (Cycle 17)

  Top
Novel Cell-matrix Markers and Drivers of Breast Cancer
Award: $262,500
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Breast Cancer-secreted MicroRNAs in the Pre-metastatic Niche
Award: $252,000
Institution: Beckman Research Institute of the City of Hope Subject Area: Pathogenesis
Targeting Prolactin as a Novel Treatment for Breast Cancer
Award: $150,000
Institution: University of California, Riverside Subject Area: Innovative Treatments
Targeting Histone Acetyltransferase in Triple Negative BC
Award: $272,995
Institution: Torrey Pines Institute for Molecular Studies Subject Area: Innovative Treatments
Identifying Novel Drugable Targets Against TNBC
Award: $150,000
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Molecular classification of early breast neoplasia
Award: $156,561
Institution: Stanford University Subject Area: Pathogenesis
Soy, DNA Methylation and Breast Cancer
Award: $244,524
Institution: University of Southern California Subject Area: Prevention & Risk Reduction
Epigenetic changes as modifiers of BRCA1/ BRCA2 cancer risk
Award: $251,128
Institution: Beckman Research Institute of the City of Hope Subject Area: Etiology
Cadmium, Age at Menarche, and Early Puberty in Girls
Award: $204,553
Institution: Cancer Prevention Institute of California Subject Area: Etiology
Cost-effectiveness Analysis to Inform BC Screening Policy
Award: $149,996
Institution: University of California, Davis Subject Area: Health Policy & Health Services

2010 (Cycle 16)

  Top
HER2 Co-Amplified Genes and Treatment Response
Award: $241,988
Institution: University of Southern California Subject Area: Innovative Treatments
Reelin Signaling Involvement in Breast Cancer Cell Migration
Award: $149,493
Institution: University of California, Los Angeles Subject Area: Pathogenesis
Targeting Drug Resistant Breast Cancer by microRNAs
Award: $100,000
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Enhancing Trastuzumab Therapy with an NK Activating Antibody
Award: $224,749
Institution: Stanford University Subject Area: Innovative Treatments
Complement-mediated Stem Cell Recruitment to Breast Cancer
Award: $136,500
Institution: Torrey Pines Institute for Molecular Studies Subject Area: Pathogenesis
Targeting Brain Metastasis with a Cell-based Approach
Award: $284,354
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Inhibiting Breast Cancer Brain Metastasis with Cilengitide
Award: $284,435
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Receptor Re-expression in ER and PR Negative Breast Cancer
Award: $18,203
Institution: University of Southern California Subject Area: Innovative Treatments
Salivary Biomarkers for Early Detection of Breast Cancer
Award: $123,748
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
New Estrogen Receptor Downregulators for Breast Cancer
Award: $150,000
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Multimarker miR Blood Assay for Breast Cancer Detection
Award: $265,415
Institution: John Wayne Cancer Institute Subject Area: Innovative Treatments
Vitamin D and Breast Cancer Survival
Award: $220,132
Institution: Cancer Prevention Institute of California Subject Area: Prevention & Risk Reduction
Light at Night and Breast Cancer Risk in California Teachers
Award: $197,333
Institution: Cancer Prevention Institute of California Subject Area: Prevention & Risk Reduction
Myeloperoxidase Mediated Protection in Breast Cancer
Award: $286,500
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Breast Cancer Neoadjuvant Chemotherapy Response with miRNA
Award: $249,000
Institution: Beckman Research Institute of the City of Hope Subject Area: Innovative Treatments
Local Adipocyte Function in Breast Cancer
Award: $272,993
Institution: Torrey Pines Institute for Molecular Studies Subject Area: Pathogenesis
p97 as a Therapeutic Target in Breast Cancer Metastasis
Award: $292,500
Institution: Proteomics Research Institute for Systems Medicine Subject Area: Pathogenesis
Inhibiting Mutation to Prevent and Treat Breast Cancer
Award: $63,021
Institution: Scripps Research Institute Subject Area: Pathogenesis

2009 (Cycle 15)

  Top
Novel Tumor Suppressors in Breast Development and Cancer
Award: $230,373
Institution: Stanford University Subject Area: Biology of the Normal Breast
Proline Metabolism in Metastatic Breast Cancer
Award: $284,895
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
A Molecular Strategy to Inhibit Breast Cancer Metastasis
Award: $150,000
Institution: University of California, San Francisco Subject Area: Pathogenesis
Antibody-based Targeting of Breast Cancer Stem Cells
Award: $150,000
Institution: University of California, Santa Barbara Subject Area: Innovative Treatments
Inhibitors of Condensin I as Chemotherapy for Breast Cancer
Award: $100,000
Institution: University of California, Irvine Subject Area: Innovative Treatments
Reducing Surgical Morbidity of Breast Cancer Staging
Award: $149,983
Institution: University of California, Davis Subject Area: Innovative Treatments
Discovery of Fusion Genes in Breast Cancer
Award: $160,000
Institution: Stanford University Subject Area: Pathogenesis
Breast Cancer Tumor-Stroma Interactions in an In Vivo Model
Award: $279,336
Institution: Vaccine Research Institute of San Diego Subject Area: Pathogenesis
Targeting DNA Repair Function of Breast Cancer Stem Cells
Award: $284,660
Institution: Scripps Research Institute Subject Area: Innovative Treatments
The Role of EGF Variant mLEEK and Grp78 in Breast Cancer
Award: $241,380
Institution: Stanford University Subject Area: Pathogenesis
Survival in de novo and Recurrent Metastatic Breast Cancer
Award: $249,000
Institution: Beckman Research Institute of the City of Hope Subject Area: Innovative Treatments
Role of p68 in Breast Cancer
Award: $165,335
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Metabolite Imaging to Identify Drug Resistant Breast Cancer
Award: $171,892
Institution: Lawrence Berkeley National Laboratory Subject Area: Innovative Treatments
Combating Breast Cancer with the Wellderly Immune Repertoire
Award: $284,718
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Finding BRCA1 Ubiquitinated Substrates in Breast Cancer
Award: $191,000
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Health Literacy in Older Patient's Breast Cancer Treatment
Award: $180,890
Institution: University of California, Los Angeles Subject Area: Sociocultural, Behavioral, and Psychological Issues
Podocalyxin as a Basal-like Breast Cancer Stem Cell Marker
Award: $243,676
Institution: University of Southern California Subject Area: Pathogenesis
Membrane-associated Estrogen Receptors in Breast Cancer
Award: $149,119
Institution: University of California, Los Angeles Subject Area: Pathogenesis
Patient and Clinician Knowledge of Breast Cancer Lymphedema
Award: $227,784
Institution: Kaiser Foundation Research Institute Subject Area: Sociocultural, Behavioral, and Psychological Issues

2008 (Cycle 14)

  Top
FGFR2 Signaling in Human Breast Cancer Cells
Award: $100,000
Institution: University of California, San Diego Subject Area: Etiology
Treating BC Brain Metastases with Cytotoxic Lymphocytes
Award: $186,496
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
Nanolipoproteins to Study Breast Cancer Growth Receptors
Award: $99,000
Institution: University of California, Davis Subject Area: Pathogenesis
Inhibition of TF Signaling as a Novel Breast Cancer Therapy
Award: $284,250
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Maternal Embryonic Leucine Zipper Kinase in Mammary Tumors
Award: $286,500
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Quality of Mammography Facilities Serving Vulnerable Women
Award: $150,000
Institution: University of California, San Francisco Subject Area: Disparities
Pesticide and Gene Interactions in Latina Farm Workers
Award: $160,718
Institution: University of California, San Francisco Subject Area: Etiology
Grapefruit, Hormones, and Postmenopausal Breast Cancer Risk
Award: $243,717
Institution: University of Southern California Subject Area: Etiology
Treating BC Brain Metastases with Cytotoxic Lymphocytes
Award: $105,538
Institution: Torrey Pines Institute for Molecular Studies Subject Area: Innovative Treatments
Antidepressants and Breast Cancer Treatment Interactions
Award: $156,068
Institution: Kaiser Foundation Research Institute Subject Area: Etiology
Novel Small Proteins for PET Imaging of Breast Cancer
Award: $261,806
Institution: Stanford University Subject Area: Imaging, Biomarkers, & Molecular Pathology
Imaging of Novel Stem Cell Therapy Targeting Breast Cancer
Award: $239,213
Institution: Stanford University Subject Area: Innovative Treatments

2007 (Cycle 13)

  Top
Multinuclear MRI of Breast Tumors
Award: $236,771
Institution: Stanford University Subject Area: Imaging, Biomarkers, & Molecular Pathology
Exploring the Role of PARP Inhibitors in Breast Cancer
Award: $157,516
Institution: Stanford University Subject Area: Etiology
Circuit Training to Lower Breast Cancer Risk in Latina Teens
Award: $244,374
Institution: University of Southern California Subject Area: Prevention & Risk Reduction
Determination of Stromal Gene Expression in Breast Cancer
Award: $136,217
Institution: Palo Alto Veterans Institute for Research Subject Area: Pathogenesis
Lipid Raft Composition in Deregulated ERBB2 Signaling
Award: $99,371
Institution: University of California, Los Angeles Subject Area: Pathogenesis
Novel Cytokine Immunotherapy for Breast Cancer
Award: $150,000
Institution: University of California, San Diego Subject Area: Innovative Treatments
Molecular Imaging of Metastatic Lymph Nodes in Breast Cancer
Award: $149,600
Institution: University of California, San Francisco Subject Area: Imaging, Biomarkers, & Molecular Pathology
Breast Cancer Treatment Monitoring Combining MRI and Optics
Award: $113,166
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Modulation of Breast Cancer Stem Cell Response to Radiation
Award: $149,377
Institution: University of California, Los Angeles Subject Area: Innovative Treatments

2006 (Cycle 12)

  Top
Role of Cell Division Asymmetry in Breast Cancer Stem Cells
Award: $149,990
Institution: University of California, San Francisco Subject Area: Pathogenesis
Artemisinin Disrupts Estrogen Receptor-Alpha and Cell Growth
Award: $100,000
Institution: University of California, Berkeley Subject Area: Innovative Treatments
A Candidate Marker of Mammary Tumor Initiating Cells
Award: $284,262
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
A New Marker for Mammary Epithelial Stem Cells?
Award: $188,827
Institution: The Burnham Institute for Medical Research Subject Area: Biology of the Normal Breast
Identification of Metastasis Competent Breast Cancer Cells
Award: $267,567
Institution: La Jolla Institute for Molecular Medicine Subject Area: Pathogenesis
A Novel Biological Framework for the Role of Xenoestrogens
Award: $279,242
Institution: California Pacific Medical Center Research Institute Subject Area: Etiology
The Role of Estrogen-Related Receptors in Breast Cancer
Award: $278,106
Institution: Scripps Research Institute Subject Area: Pathogenesis
Twist Activation in Breast Cancer Metastasis
Award: $150,000
Institution: University of California, San Diego Subject Area: Pathogenesis
Combined Imaging Modalities for Breast Cancer
Award: $149,162
Institution: University of California, Irvine Subject Area: Imaging, Biomarkers, & Molecular Pathology
rADDs: Novel Disintegrins Targeting Breast Cancer
Award: $244,500
Institution: University of Southern California Subject Area: Innovative Treatments
Intraoperative Assessment of Surgical Lumpectomy Margins
Award: $268,810
Institution: John Wayne Cancer Institute Subject Area: Innovative Treatments
Neural Stem Cell Therapy for Breast Cancer Brain Metastases
Award: $302,085
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Topoisomerase-IIa as a Predictor of Anthracycline Response
Award: $244,499
Institution: University of Southern California Subject Area: Innovative Treatments
Hereditary Breast Cancer and Novel Hispanic BRCA Mutations
Award: $253,500
Institution: Beckman Research Institute of the City of Hope Subject Area: Etiology
Neighborhood Environment and Obesity in Pre-adolescent Girls
Award: $162,847
Institution: University of California, San Francisco Subject Area: Disparities
Inhibition of Breast Cancer Aggressiveness by Cannabidiol
Award: $183,000
Institution: California Pacific Medical Center Research Institute Subject Area: Innovative Treatments
Identification of Metastasis Competent Breast Cancer Cells
Award: $59,805
Institution: Sidney Kimmel Cancer Center Subject Area: Pathogenesis
Breast Cancer Metastasis: a Heritable Trait?
Award: $264,595
Institution: Stanford University Subject Area: Etiology
Breast Tumor Inhibition by Vitamin D in a Mouse Model
Award: $234,388
Institution: Stanford University Subject Area: Innovative Treatments
A Targeted Therapy for Wound-like Breast Cancers
Award: $232,934
Institution: Stanford University Subject Area: Innovative Treatments
Vascular Targeting Therapy for Breast Cancer
Award: $288,728
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
New Technology to Enhance PET Imaging of Breast Cancer
Award: $154,879
Institution: Stanford University Subject Area: Imaging, Biomarkers, & Molecular Pathology
Nur77-derived Peptides as a Novel Breast Cancer Therapy
Award: $286,108
Institution: The Burnham Institute for Medical Research Subject Area: Innovative Treatments

2005 (Cycle 11)

  Top
Stem Cells of Molecularly Diverse ER-Negative Breast Cancers
Award: $234,165
Institution: Stanford University Subject Area: Pathogenesis
A Novel Epithelial-Stromal Model of Metastatic Breast Cancer
Award: $205,716
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
The Role of B-Myb in Human Breast Cancer Progression
Award: $156,106
Institution: Stanford University Subject Area: Pathogenesis
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Award: $234,071
Institution: Stanford University Subject Area: Etiology
Role of Telomerase in Mammary Stem Cell Function
Award: $236,379
Institution: Stanford University Subject Area: Biology of the Normal Breast
Molecular Imaging of Breast Cancer Using Breast PET/CT
Award: $99,907
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology
Inhibition of Brain Metastases in Breast Cancer
Award: $278,850
Institution: Scripps Research Institute Subject Area: Innovative Treatments
ID4: a Prognostic Factor of Breast Cancer Metastasis
Award: $283,200
Institution: John Wayne Cancer Institute Subject Area: Innovative Treatments
Defining Mammary Cancer Origins in a Mouse Model of DCIS
Award: $149,950
Institution: University of California, Davis Subject Area: Pathogenesis
Novel Approach to Analyze Estrogen Action in Breast Cancer
Award: $310,950
Institution: La Jolla Institute for Molecular Medicine Subject Area: Pathogenesis
Histone Methylation as a Marker of Breast Cancer Progression
Award: $162,500
Institution: University of Southern California Subject Area: Pathogenesis
Structural Analysis of Cancer-Relevant BCRA2 Mutations
Award: $100,000
Institution: University of California, Davis Subject Area: Pathogenesis
The Role of the ECM in Breast Cancer DNA Damage Repair
Award: $250,560
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
HER3 Infidelity and Resistance to Tyrosine Kinase Inhibitors
Award: $150,000
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Breast Cancer Risk Associated with High Mammographic Density
Award: $148,163
Institution: University of California, San Francisco Subject Area: Prevention & Risk Reduction
Estrogen Receptor Beta Agonists to Prevent Breast Cancer
Award: $150,000
Institution: University of California, San Francisco Subject Area: Prevention & Risk Reduction
Grape Seed as a Natural Breast Cancer Chemopreventive Agent
Award: $251,381
Institution: Beckman Research Institute of the City of Hope Subject Area: Prevention & Risk Reduction
Targeted Chemoprevention in a Mouse Model for DCIS
Award: $135,326
Institution: University of California, Davis Subject Area: Prevention & Risk Reduction
New Breast Cancer Approaches: Integration, Communication
Award: $150,000
Institution: University of California, San Francisco Subject Area: Health Policy & Health Services
Effect of Bright Light on Fatigue in Breast Cancer
Award: $141,282
Institution: University of California, San Diego Subject Area: Sociocultural, Behavioral, and Psychological Issues
Early Breast Cancer Detection Using 3D Ultrasound Tomography
Award: $149,879
Institution: University of California, San Diego Subject Area: Imaging, Biomarkers, & Molecular Pathology
Survivin: Target for Breast Cancer Brain Metastases
Award: $242,854
Institution: University of Southern California Subject Area: Pathogenesis
Breast Cancer Studies in a 3-D Cell Culture System
Award: $188,602
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis

2004 (Cycle 10)

  Top
Characterizing Breast Cancer Cells in Blood and Bone Marrow
Award: $155,781
Institution: Stanford University Subject Area: Pathogenesis
Living Well With Advanced Breast Cancer: A Predictive Model
Award: $99,982
Institution: University of California, Los Angeles Subject Area: Sociocultural, Behavioral, and Psychological Issues
Epithelial Polarity, Organization and the Angiogenic Switch
Award: $75,000
Institution: University of California, San Francisco Subject Area: Biology of the Normal Breast
Assessing Recurrent Genomic Aberrations Linked to Ethnicity
Award: $100,000
Institution: University of California, San Francisco Subject Area: Disparities
PBDEs in Tissues of Women With and Without Breast Cancer
Award: $67,779
Institution: Public Health Institute Subject Area: Etiology
Discovering Novel Cell-ECM Interactions in Breast Cells
Award: $159,939
Institution: California Pacific Medical Center Research Institute Subject Area: Biology of the Normal Breast
Psychobiological Concomitants: Bereaved Women at Br Ca Risk
Award: $94,738
Institution: University of California, Los Angeles Subject Area: Sociocultural, Behavioral, and Psychological Issues
Identifying Metastatic Breast Cells from Peripheral Blood
Award: $203,223
Institution: Lawrence Livermore National Laboratory Subject Area: Pathogenesis

2003 (Cycle IX)

  Top
Src Signaling in Breast Cancer
Award: $75,000
Institution: University of California, Berkeley Subject Area: Pathogenesis
Alternative pre-mRNA Splicing in Mammary Epithelial Cells
Award: $119,968
Institution: Lawrence Berkeley National Laboratory Subject Area: Biology of the Normal Breast
Glycoconjugates: Novel Non-toxic Therapies for Breast Cancer
Award: $191,278
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
Prolactin and Breast Cancer Risk in a Multiethnic Cohort
Award: $160,843
Institution: University of Southern California Subject Area: Etiology
Identification of BRCA1 Ubiquitylation Targets
Award: $75,000
Institution: University of California, Irvine Subject Area: Biology of the Normal Breast
Pilot Studies of Breast Cancer Immunophototherapy
Award: $99,834
Institution: University of California, Irvine Subject Area: Innovative Treatments
Assessing the Impact of Shame and Guilt in Recovery
Award: $152,094
Institution: Stanford University Subject Area: Sociocultural, Behavioral, and Psychological Issues

2002 (Cycle VIII)

  Top
Can Placenta Factors Explain Race Patterns of Breast Cancer?
Award: $84,502
Institution: Public Health Institute Subject Area: Disparities
Defining a Role for Endothelial Precursor Cells in Breast
Award: $199,174
Institution: La Jolla Institute for Molecular Medicine Subject Area: Biology of the Normal Breast
Clotting Breast Cancer
Award: $98,986
Institution: University of California, Irvine Subject Area: Innovative Treatments
A Novel Anti-estrogen Resistance Mechanism in Breast Cancer
Award: $143,250
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Global Gene Regulation by SATB1 in Metastatic Breast Cancer
Award: $161,176
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
MMP-Directed Synthesis of Invasive Breast Cancer Blockers
Award: $135,298
Institution: Scripps Research Institute Subject Area: Innovative Treatments
Identifying Sources of Genomic Instability in Breast Cancer
Award: $119,059
Institution: Stanford University Subject Area: Pathogenesis
Weight Loss in Public Hospital Breast Cancer Patients
Award: $140,541
Institution: LA Biomedical Research Institute at Harbor-UCLA Medical Center Subject Area: Sociocultural, Behavioral, and Psychological Issues

2001 (Cycle VII)

  Top
Novel Enzymes Associated with Breast Cancer Angiogensis
Award: $100,000
Institution: University of California, San Francisco Subject Area: Pathogenesis
Are EGF-Receptors Activated by IL-8 in Breast Cancer?
Award: $155,475
Institution: La Jolla Institute for Molecular Medicine Subject Area: Pathogenesis
Targeting of Tumor-Promoting Galectins in Breast Cancer
Award: $182,500
Institution: Sidney Kimmel Cancer Center Subject Area: Imaging, Biomarkers, & Molecular Pathology
Evaluation of Essiac Tea to Prevent Mammary Tumors
Award: $182,593
Institution: Lawrence Livermore National Laboratory Subject Area: Prevention & Risk Reduction
LPC as a Potential Tumor Marker for Recurrent Breast Cancer
Award: $100,000
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology
Novel Technologies to Identify Tissue-Selective Estrogens
Award: $75,000
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Rodent Model for Human Ductal Carcinoma in Situ
Award: $100,000
Institution: University of California, Berkeley Subject Area: Pathogenesis
Smoking Effect on Pulmonary Metastasis from Breast Cancer
Award: $74,968
Institution: University of California, Davis Subject Area: Pathogenesis

2000 (Cycle VI)

  Top
Mammography Density and Sex Steroid Genes
Award: $102,328
Institution: University of Southern California Subject Area: Etiology
DNA Polymorphisms and Breast Cancer in a Multi-ethnic Cohort
Award: $80,949
Institution: University of Southern California Subject Area: Etiology
Race/Ethnicity, Socioeconomic Status and Breast Cancer
Award: $38,258
Institution: Public Health Institute Subject Area: Health Policy & Health Services
Arginine Deiminase as an Innovative Anti-Breast Cancer Agent
Award: $81,507
Institution: University of Southern California Subject Area: Innovative Treatments
A Novel Antigen Associated with Breast Cancer Metastasis
Award: $135,132
Institution: Sidney Kimmel Cancer Center Subject Area: Pathogenesis

1999 (Cycle V)

  Top
Postmenopausal Breast Cancer: Obesity & the Leptin Receptor
Award: $97,677
Institution: University of Southern California Subject Area: Etiology
Breast Cancer Susceptibility Genes in Very High Risk Women
Award: $129,247
Institution: University of Southern California Subject Area: Etiology
Exercise, Hormones and Breast Cancer Prevention
Award: $142,451
Institution: University of Southern California Subject Area: Prevention & Risk Reduction
Id-1 Expression During Breast Cancer Progression
Award: $78,031
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Identification of Novel Secreted Proteins of Breast Cancer
Award: $75,750
Institution: Cedars-Sinai Medical Center Subject Area: Imaging, Biomarkers, & Molecular Pathology
Role of Chemokine Receptors in Breast Cancer Metastasis
Award: $41,311
Institution: University of California, Los Angeles Subject Area: Pathogenesis
Novel Breast Cancer Anti-Angiogenic Compounds
Award: $67,611
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Impact of Opioid Peptides on Breast Cancer Etiology
Award: $0
Institution: Lawrence Livermore National Laboratory Subject Area: Etiology

1998 (Cycle IV)

  Top
Sentinel Node Detection via Targeted Fluorescence
Award: $41,259
Institution: University of California, San Diego Subject Area: Imaging, Biomarkers, & Molecular Pathology
The Role of a Newly Discovered Neuregulin in Breast Cancer
Award: $87,472
Institution: Scripps Research Institute Subject Area: Pathogenesis
Development of EGFR-Based Imaging Agents for Breast Cancer
Award: $69,580
Institution: Lawrence Berkeley National Laboratory Subject Area: Imaging, Biomarkers, & Molecular Pathology
Intracellular Signaling by PI3K in Breast Cancer Metastasis
Award: $43,329
Institution: University of California, Davis Subject Area: Pathogenesis
Measurement of Breast Tissue Viscoelasticity Using MRI
Award: $48,396
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology

1997 (Cycle III)

  Top
Identification of Pregnancy-associated Breast Cancer Genes
Award: $50,000
Institution: University of California, Berkeley Subject Area: Prevention & Risk Reduction
Fate Mapping of Progesterone Receptor Positive Breast Cells
Award: $243,380
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Does Cell Aging Cause Breast Cancer?
Award: $239,303
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Breast Cancer Incidence in California Flight Attendants
Award: $56,922
Institution: Public Health Institute Subject Area: Etiology
Recombination and Mutation in Breast Cancer
Award: $260,988
Institution: Pangene Corporation Subject Area: Pathogenesis
Galectin-4 As a New Marker for Breast Cancer
Award: $196,900
Institution: La Jolla Institute for Allergy and Immunology Subject Area: Imaging, Biomarkers, & Molecular Pathology
Analysis of Rac Mutations in Breast Cancer
Award: $87,413
Institution: Scripps Research Institute Subject Area: Pathogenesis
Reprogramming Breast Cancer Epithelial Cells
Award: $97,500
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Estrogen Formation and Breast Cancer Risk
Award: $244,889
Institution: University of Southern California Subject Area: Etiology
Autoantibodies in Breast Cancer
Award: $130,130
Institution: Scripps Research Institute Subject Area: Pathogenesis
Vitamin D Receptor Gene and Breast Cancer Risk
Award: $241,803
Institution: University of Southern California Subject Area: Etiology
Growth Factor Receptor Activation in Breast Cancer
Award: $267,291
Institution: Scripps Research Institute Subject Area: Pathogenesis
Dietary Indole Inhibition of Breast Cancer
Award: $150,000
Institution: University of California, Berkeley Subject Area: Prevention & Risk Reduction
The Role of a Novel Estrogen Receptor in Breast Cancer
Award: $231,039
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Novel Breast Cancer Epithelial Cell Metalloproteinase
Award: $193,995
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Molecular Karyotyping of Breast Cancer by DNA Fingerprinting
Award: $290,550
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Identifying Novel Breast Cancer Tumor Suppressor Genes
Award: $97,500
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Hormonal Control of HER2neu and BRCA1 in Breast Cancer
Award: $286,676
Institution: Sidney Kimmel Cancer Center Subject Area: Pathogenesis
Bovine Leukemia Virus and Human breast Cancer Risk
Award: $150,001
Institution: University of California, Berkeley Subject Area: Etiology
New imaging Modality for Early Detection of Breast Cancer
Award: $149,500
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology
Computer-Aided Diagnosis in Digital Mammography
Award: $214,200
Institution: Charles R. Drew University of Medicine & Science Subject Area: Imaging, Biomarkers, & Molecular Pathology
Nitric Oxide's Role in Breast Cancer Metabolism and Growth
Award: $74,000
Institution: City of Hope National Medical Center Subject Area: Etiology
MRI Detection of Breast Cancer Blood Vessels
Award: $149,935
Institution: University of California, Irvine Subject Area: Imaging, Biomarkers, & Molecular Pathology

1996 (Cycle II)

  Top
Bovine leukemia virus and human breast cancer risk
Award: $50,000
Institution: University of California, Berkeley Subject Area: Etiology
Breast Cancer and Genetic Differences in Estrogen Formation
Award: $81,598
Institution: University of Southern California Subject Area: Etiology
Novel Agent for Lymph Node Imaging and Targeted Gene Therapy
Award: $40,912
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology
Altering telomerase to prevent breast cancer progression
Award: $44,677
Institution: University of California, San Francisco Subject Area: Pathogenesis
Engineered antibodies for imaging & therapy of breast cancer
Award: $87,924
Institution: Beckman Research Institute of the City of Hope Subject Area: Innovative Treatments
Why do 70% of Breast Cancers Metastasize to Bone?
Award: $97,407
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Non-Invasive Optical Detection of Breast Cancer
Award: $50,000
Institution: University of California, Irvine Subject Area: Imaging, Biomarkers, & Molecular Pathology
Proper relocation of a tumor suppressor in Breast Cancer
Award: $50,000
Institution: University of California, Irvine Subject Area: Pathogenesis

1995 (Cycle I)

  Top
Understanding Breast Cancer Screening in Filipino Women
Award: $50,057
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology
Biology of Telomere Length Conservation in Breast Cancer
Award: $78,798
Institution: University of Southern California Subject Area: Pathogenesis
Magnetic Resonance Measurement of Breast Tissue Perfusion
Award: $48,560
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology
Blocking Breast Cancer Progression with Radioactive Antibody
Award: $50,000
Institution: University of California, Irvine Subject Area: Innovative Treatments
Ultrasound Computed Tomography for Breast Lesion Detection
Award: $45,382
Institution: University of California, San Diego Subject Area: Imaging, Biomarkers, & Molecular Pathology
Vitamin D & Genetics of Vitamin D Receptor in Breast Cancer
Award: $80,976
Institution: University of Southern California Subject Area: Etiology
Progesterone Action in Human Breast Cancer
Award: $85,733
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Regulatory Mechanisms for Growth & Motility in Breast Cancer
Award: $82,900
Institution: Scripps Research Institute Subject Area: Pathogenesis
Platelet factor 4: A Marker For Malignant Breast Tumors
Award: $95,380
Institution: La Jolla Institute for Molecular Medicine Subject Area: Imaging, Biomarkers, & Molecular Pathology
New Method for Measuring Breast Cancer Gene Expression
Award: $85,706
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
New Imaging Modality for Early Detection of Breast Cancer
Award: $49,516
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology
Group Intervention for Women at High Risk for Breast Cancer
Award: $42,836
Institution: University of California, Los Angeles Subject Area: Sociocultural, Behavioral, and Psychological Issues
Genetic Susceptibility to Breast Cancer
Award: $79,669
Institution: University of Southern California Subject Area: Etiology